Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family

Colorectal cancer (CRC) is among the most frequent causes of cancer-related deaths worldwide. Thus, there is a need for the development of new therapeutic approaches for the treatment of CRC. Accumulating evidence has revealed that niclosamide, an anthelminthic drug, exerts antitumor activity in sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Suliman, Mohammed A., Zhang, Zhenxing, Na, Heya, Ribeiro, Ailton L.L., Zhang, Yu, Niang, Bachir, Hamid, Abdu Salim, Zhang, Hua, Xu, Lijie, Zuo, Yunfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990307/
https://www.ncbi.nlm.nih.gov/pubmed/27460529
http://dx.doi.org/10.3892/ijmm.2016.2689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990307/
https://www.ncbi.nlm.nih.gov/pubmed/27460529
http://dx.doi.org/10.3892/ijmm.2016.2689

Ejemplares similares